Carson City, Nevada, March 19, 2018, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN), (“Cell MedX” or the “Company”), a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes has arranged a non-brokered…
Carson City, Nevada, January 30, 2018, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN), (“Cell MedX” or the “Company”), is an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness.…
Carson City, Nevada, January 29, 2018, Cell MedX Corp. (OTCQB: CMXC; 9CX:MUN), (“Cell MedX” or the “Company”), announces that it has been assigned a Legal Entity Identifier number 967600RJ7LKTH79OWE67. About the Legal Entity Identifier Number (“LEI”) The European Union has…
Carson City, Nevada, January 24, 2018, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased…
Carson City, Nevada, December 5, 2017, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased…
Carson City, Nevada, August 31, 2017, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is excited…
Carson City, Nevada, July 31, 2017, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is excited…
Carson City, Nevada, July 5, 2017, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is excited…
Carson City, Nevada, April 26, 2017, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), is pleased to announce that the Company’s Canadian subsidiary has entered into a production agreement with an ISO 9001 certified manufacturing facility in Coquitlam,…
Carson City, Nevada, March 28, 2017, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), announced that it has completed its registration process with U.S. Food and Drug Administration (“FDA”) and has initiated an application process to receive FDA…